raltegravir
Summary
Raltegravir is an antiretroviral agent used for the treatment of HIV infections in conjunction with other antiretrovirals.
Brand Names: Isentress
Generic Name: Raltegravir
Background
Raltegravir is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval.
Type: Small Molecule
Weight Average: 444.4163
Monoisotopic: 444.155746017
Chemical Formula: C20H21FN6O5